Skip to content

Management of Sleep Apnea Patients by a Clinical Nurse (Supernurse)

Management of Sleep Apnea Patients by a Clinical Nurse (Supernurse)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03455920
Enrollment
200
Registered
2018-03-07
Start date
2017-12-19
Completion date
2020-04-30
Last updated
2020-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multidisciplinary Communication, Sleep Apnea, Sleep Apnea, Obstructive, Sleep Apnea Syndromes

Brief summary

Sleep apnea is a prevalent problem and references for the evaluation of this condition often exceeds the sleep clinic's capacity thus creating important delays in the patients' care. The overall goal of this project is to assess the feasibility and the non-inferiority of integrating a clinical nurse, or supernurse, to the initial consultation team. The hypothesis is that the integration of a clinical nurse to the sleep clinic's evaluation team is non inferior in terms of patients' outcomes such as improvement of symptoms and quality of life as well as adherence to treatment. This study is supported by funding dedicated to teaching and research activities related to sleep-disordered breathing.

Interventions

OTHERClinical nurse (supernurse) evaluation

The first evaluation of the patient refered to the sleep clinic will be performed by the clinical nurse then discussed with the pulmonologist in charge.

The first evaluation of the patient refered to the sleep clinic will be performed only by the pulmonologist.

Sponsors

Laval University
CollaboratorOTHER
Annie C Lajoie
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients referred to the ''Institut Universitaire de Cardiologie et Pneumologie de Québec'' 's sleep clinic who have undergone a cardiorespiratory polygraphy. * Body mass index (BMI) between 27-35 kg/m2; * Apnea-Hypopnea Index (ADI) equal or above 20 events per hour with less than 5 events per hour of central origin; * Oxygen Desaturaton Index (ODI) equal or above 10 events per hour; * Percentage of time spent below 90% of oxygen saturation equal or less than 10%

Exclusion criteria

: \- Patients not meeting the above inclusion criteria.

Design outcomes

Primary

MeasureTime frameDescription
Improvement in symptomsAssessed at three monthsBased on the Epworth Sleepiness scale (ranging from 0 to 24 points, higher values indicates increased sleepiness)

Secondary

MeasureTime frameDescription
Improvement in quality of lifeAssessed at three monthsBased on the Quebec Sleep questionnaire
Positive pressure treatment adherenceAssessed at six monthsNumber of hours used per night according to CPAP report
Mandibular advancement device treatment adherenceAssessed at six monthsAccording to the patient's usage report
Weight loss treatment adherenceAssessed at six monthsChanges from baseline weight (kg)
Positional therapyAssessed at six monthsProportion of time spent supine at baseline and at control cardio-respiratory recording

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026